NYSEArca - Nasdaq Real Time Price USD

VanEck Indonesia Index ETF (IDX)

15.84 +0.09 (+0.57%)
As of 10:45 AM EDT. Market Open.
Loading Chart for IDX
DELL
  • Previous Close 15.75
  • Open 15.84
  • Bid 15.83 x 1100
  • Ask 15.85 x 1100
  • Day's Range 15.83 - 15.84
  • 52 Week Range 15.57 - 18.82
  • Volume 7,142
  • Avg. Volume 9,377
  • Net Assets 27.68M
  • NAV 15.77
  • PE Ratio (TTM) 7.88
  • Yield 3.79%
  • YTD Daily Total Return -7.73%
  • Beta (5Y Monthly) 0.45
  • Expense Ratio (net) 0.57%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes securities of Indonesian companies. A company is generally considered to be an Indonesian company if it is incorporated in Indonesia or is incorporated outside of Indonesia but has at least 50% of its revenues/related assets in Indonesia. Such companies may include small- and medium-capitalization companies. It is non-diversified.

VanEck

Fund Family

Miscellaneous Region

Fund Category

27.68M

Net Assets

2009-01-15

Inception Date

Performance Overview: IDX

Trailing returns as of 4/23/2024. Category is Miscellaneous Region.

YTD Return

IDX
7.73%
Category
--
 

1-Year Return

IDX
8.27%
Category
--
 

3-Year Return

IDX
3.72%
Category
--
 

People Also Watch

Holdings: IDX

Top 10 Holdings (56.18% of Total Assets)

SymbolCompany% Assets
BBCA.JK
PT Bank Central Asia Tbk 8.09%
BBRI.JK
PT Bank Rakyat Indonesia (Persero) Tbk 7.81%
BMRI.JK
PT Bank Mandiri (Persero) Tbk 7.12%
AMMN.JK
PT Amman Mineral Internasional Tbk 6.24%
TLK
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk 5.90%
ASII.JK
PT Astra International Tbk 5.46%
BREN.JK
PT Barito Renewables Energy Tbk 4.47%
BBNI.JK
PT Bank Negara Indonesia (Persero) Tbk 4.45%
GOTO.JK
PT GoTo Gojek Tokopedia Tbk 3.34%
TPIA.JK
PT Chandra Asri Pacific Tbk 3.30%

Sector Weightings

SectorIDX
Energy   6.04%
Utilities   5.27%
Technology   3.36%
Industrials   2.49%
Healthcare   2.41%
Real Estate   1.69%

Related ETF News

Research Reports: IDX

  • Analyst Report: Wipro Limited

    Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.

    Rating
    Price Target
     
  • Analyst Report: Infosys Limited

    Infosys is a leading global IT services provider, with nearly 250,000 employees. Based in Bangalore, the Indian IT services firm leverages its offshore outsourcing model to derive 60% of its revenue from North America. The company offers traditional IT services offerings: consulting, managed services and cloud infrastructure services, and business process outsourcing as a service (BPaaS).

    Rating
    Price Target
     
  • Analyst Report: Infosys Limited

    Infosys is a leading global IT services provider, with nearly 250,000 employees. Based in Bangalore, the Indian IT services firm leverages its offshore outsourcing model to derive 60% of its revenue from North America. The company offers traditional IT services offerings: consulting, managed services and cloud infrastructure services, and business process outsourcing as a service (BPaaS).

    Rating
    Price Target
     
  • Analyst Report: Dr. Reddy's Laboratories Limited

    Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

    Rating
    Price Target
     

Related Tickers